Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.5.0 released, replacing the previous v3.4.3.SummaryDifference0.0%

- Check26 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded site revision note v3.4.2 and removed prior notices about government funding lapse and NIH operating status (v3.4.1).SummaryDifference0.3%

- Check62 days agoChange DetectedAdded a Results Posted date (2026-01-30) and associated results data for the TROPiCS-03 study across multiple cohorts. Updated the trial design to non-randomized, parallel assignment and expanded cohort descriptions (NSCLC subtypes, HNSCC, EC, ES-SCLC) with revised inclusion criteria and treatment regimens.SummaryDifference5%

- Check69 days agoChange DetectedUI updates include showing the glossary toggle and updating metadata, including Last Update Submitted that Met QC Criteria, Last Update Posted, the No FEAR Act capitalization change, and Revision: v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedAdded 'Results Submitted' to the study's Results section, replacing the previous 'No Results Posted' status.SummaryDifference0.0%

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.